Thermo Fisher to Step Up R&D Spend in 2010; Expand Footprint in Low-Cost Regions | GenomeWeb

SAN FRANCISCO (GenomeWeb News) - Thermo Fisher Scientific intends to increase its R&D spending in 2010 and expand its operating footprint in a handful of low-cost regions around the world.

Speaking today to investors at the JP Morgan Healthcare Conference held here, Thermo President and CEO Marc Casper said that the firm expects its R&D investments to target three key areas: mass spectrometry, specialty diagnostics, and bioscience reagents. However, he did not provide an estimate for the planned increased investment.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."